Sorin, a global medical company, has announced the CE Mark approval and first implant of its KORA 100, a new magnetic resonance imaging (MRI) compatible pacing system.
KORA 100 SR and KORA 100 DR pacemakers when implanted with the Sorin BEFLEX pacing lead enable implanted patients to undergo magnetic resonance imaging (MRI) examination safely.
Device settings which allow safe operation during an MRI examination are automatically enabled when KORA 100 pacemakers detect the scanner’s magnetic field. The devices sense when a patient leaves the MRI field, and return to normal operation within five minutes.
The KORA 100 pacing systems feature Sorin’s proprietary SafeR algorithm, the recently introduced sleep apnea monitoring function, and the patented Automatic MRI mode.
The SafeR pacing mode has been shown to nearly eliminate deleterious left ventricular pacing thus reducing the risk of atrial fibrillation.
The sleep apnea monitoring function is an easy-to-use diagnostic algorithm designed to screen and monitor severe sleep apnea, a significant co-morbidity related to heart failure.
Automatic MRI mode limits the amount of time that KORA 100 pacemakers operate in MRI mode.
Sorin CRM business unit president Stefano Di Lullo noted the KORA 100 with the company’s proprietary SafeR algorithm, sleep apnea monitoring, and the patented automatic MRI mode is the clear gold standard in pacing technology today.
"We are very proud to launch this latest innovative technology from Sorin Group," Lullo added.
Landesklinikum St. Polten, Austria, cardiologist Dr Christian Wollmann has performed the implantation of the first KORA 100 in a 79-year old man.
Image: Sorin obtains CE Mark approval for Kora 100 pacing system Photo: Courtesy of Sorin Group